HDAC2 and chronic obstructive pulmonary disease: The most confirmed epigenetic enzyme in COPD is histone deacetylase 2 (HDAC2), and its reduction is considered to be linked to airway inflammation amplification and glucocorticoid resistance in COPD treatment (Barnes, 2009; Lai et al., 2018).